An Evaluation of Cage Amine Sarcophagine Ligands for the Synthesis of Cobalt Radiopharmaceuticals
Inorganic Chemistry · 2026
DOI: 10.1021/acs.inorgchem.6c01482 ↗Kurz gefasst
Fachartikel in der Zeitschrift Inorganic Chemistry, 2026. Verfasst von Hailey A Houson und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, University of Alabama at Birmingham, Birmingham, Alabama 35294, United States. Hauptthemen laut MEDLINE: Radiopharmaceuticals, Amines, Cobalt, Coordination Complexes. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health and Medical Research Council, Australian Research Council.
Abstract (Originalsprache)
Positron-emitting cobalt-55 (t1/2 = 17.53 h, β+ = 77%, Eγ = 931.1 keV, Iγ = 75%) has the potential to be used for PET imaging and Auger electron-emitting cobalt-58m (t1/2 = 9.10 h, IC= 100%) has the potential to be used in targeted radionuclide therapy. Sarcophagines are a family of macrobicyclic cage amine ligands that form stable complexes with cobalt(III). This work investigates the potential of a derivative of sarcophagine with a pendent carboxylic acid functional group, 5-(8-methyl-3,6,10,13,16,19-hexaaza-bicyclo[6.6.6]icosan-1-ylamino)-5-oxopentanoic acid (known as MeCOSar), to serve as a ligand for cobalt-55. The cobalt(III) complex, [CoIII(MeCOSar)]3+, was synthesized and characterized as well as a complex where the MeCOSar ligand is conjugated to tumor-targeting peptide Tyr3-ocreotate, [CoIII(SarTATE)]3+. The MeCOSar and SarTATE ligands were radiolabeled with cobalt-55 to give [55Co][CoIII(MeCOSar)]n+ and [55Co][CoIII(SarTATE)] respectively and their biodistribution was evaluated in non tumor-bearing mice. The tumor uptake of [55Co][CoIII(SarTATE)] was then further evaluated in AR42J tumor-bearing mice and compared to the copper-64 complex, [64Cu][CuII(SarTATE)]. Radiolabeling SarTATE with cobalt-55 requires higher temperatures when compared to copper-64, and [55Co][CoIII(SarTATE)] has lower tumor uptake and higher liver uptake in tumor-bearing mice when compared to [64Cu][CuII(SarTATE)].
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Radiology, University of Alabama at Birmingham, Birmingham, Alabama 35294, United States.
- School of Chemistry and Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Parkville, Melbourne 3010, Australia.
ORCID-Profile: Suzanne E Lapi, Paul S Donnelly
Förderung
- National Health and Medical Research Council
- Australian Research Council
Zitieren
APA
Houson, H. A., Rudd, S. E., Fernandez, S. R., Lapi, S. E., & Donnelly, P. S. (2026). An Evaluation of Cage Amine Sarcophagine Ligands for the Synthesis of Cobalt Radiopharmaceuticals. Inorganic Chemistry. https://doi.org/10.1021/acs.inorgchem.6c01482
Vancouver
Houson HA, Rudd SE, Fernandez SR, Lapi SE, Donnelly PS. An Evaluation of Cage Amine Sarcophagine Ligands for the Synthesis of Cobalt Radiopharmaceuticals. Inorganic Chemistry. 2026. doi:10.1021/acs.inorgchem.6c01482
BibTeX
@article{Houson2026,
author = {Houson, Hailey A and Rudd, Stacey E and Fernandez, Solana R and Lapi, Suzanne E and Donnelly, Paul S},
title = {An Evaluation of Cage Amine Sarcophagine Ligands for the Synthesis of Cobalt Radiopharmaceuticals},
journal = {Inorganic Chemistry},
year = {2026},
doi = {10.1021/acs.inorgchem.6c01482}
}
EUVIMED